戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 udy enrollment, 1661 patients died (15.9% by life-table analysis).
2 l outcomes were evaluated using Kaplan-Meier life table analysis.
3      Results up to 4 years were evaluated by life table analysis.
4              Transitions are estimated using life-table analysis.
5   Statistical analysis was conducted using a life-table analysis.
6       Durability of PFSS was determined with life-table analysis.
7  were analyzed statistically and by means of life-table analysis.
8 r within 30 days), and 5-year survival, from life-table analysis.
9                                           On life-table analysis, 90-day recurrence rates with mean S
10 inical recurrence rates (intent to treat) by life-table analysis at 24 months were 50% (95% confidenc
11  and success rate (SR) were calculated using life-table analysis for both M and R short implants.
12 st, Wilcoxon matched-pairs signed-rank test, life-table analysis, Kaplan-Meier method, and log-rank t
13                                  With use of life-table analysis, overall primary and secondary 1-yea
14                               A Kaplan-Meier life-table analysis revealed that the incidence of zoste
15                                 Kaplan-Meier life table analysis showed similar survival rates at 1,
16 ion of OPMD caused marked debility, although life-table analysis showed no decrease in life expectanc
17                                              Life-table analysis showed that in patients who survived
18                                              Life-table analysis showed that the cumulative proportio
19                                          The life-table analysis showed that the group 1 patients had
20                                              Life-table analysis showed the mean times to a diagnosis
21                                              Life-table analysis shows the ipsilateral stroke-free ra
22                                           By life table analysis, the probability of detecting dyspla
23                                           By life-table analysis, the likelihood of remission during
24                                           By life-table analysis, the rate of stroke was 2.2% (95% co
25                                      We used life-table analysis to estimate gains in life expectancy
26                                           By life table analysis, we found that losartan and doxycycl
27 he 1, 2, and 5-year survival estimates using life table analysis were 72, 48, and 23%.
28                                           By life-table analysis, women were significantly less likel

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。